Marinus Pharmaceuticals, Inc.
MRNSDelisted Feb 11, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267813
Marinus Pharmaceuticals, Inc. was delisted on Feb 11, 2025; its insiders filed their last Form 4 on Feb 11, 2025; 53 institutions reported holding it in 13F filings for Q4 2024, worth $15.8M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Marinus Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- −1 vs. Q2 2023
- Shares held
- 51.1M
- +6.82M (+15.4%) vs. Q2 2023
- Total value
- $411.1M
- −$69.4M (−14.4%) vs. Q2 2023
- New holders
- 18
- 41 more added
- Sold out
- 19
- 30 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRNS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 53 | $15.8M |
| Q3 2024 | 75 | $72.9M |
| Q2 2024 | 90 | $50.6M |
| Q1 2024 | 112 | $486.5M |
| Q4 2023 | 105 | $585.2M |
| Q3 2023 | 104 | $411.1M |
| Q2 2023 | 106 | $485.0M |
| Q1 2023 | 86 | $283.9M |
| Q4 2022 | 74 | $165.6M |
| Q3 2022 | 69 | $186.9M |
| Q2 2022 | 73 | $140.6M |
| Q1 2022 | 83 | $280.4M |
| Q4 2021 | 75 | $355.7M |
| Q3 2021 | 82 | $362.0M |
| Q2 2021 | 80 | $563.3M |
| Q1 2021 | 87 | $480.3M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Marinus Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Franklin Resources Inc | 3,784,366 | $30.5M | 0.02% | +2,467,498+187.4% | Added |
| BlackRock Inc. | 4,145,643 | $33.4M | 0.00% | +247,873+6.4% | Added |
| Eventide Asset Management, LLC | 4,529,997 | $36.5M | 0.66% | +1,356,800+42.8% | Added |
| Suvretta Capital Management, LLC | 5,204,942 | $41.9M | 2.26% | +1,147,331+28.3% | Added |
| Logos Global Management LP | 0 | $0 | 0.00% | −525,000−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −390,418−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −188,722−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −171,075−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −170,901−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −122,260−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −62,600−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −62,520−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −51,718−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −44,572−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −31,162−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −23,335−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −19,874−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −13,947−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −13,240−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −11,856−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −2,446−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Tekla Capital Management LLC | – | – | – | – | Not filed |